On Friday, TG Therapeutics Inc (NASDAQ: TGTX) was 7.64% up from the session before settling in for the closing price of $29.04. A 52-week range for TGTX has been $12.84 – $36.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 3133.08%. When this article was written, the company’s average yearly earnings per share was at 22.22%. With a float of $140.52 million, this company’s outstanding shares have now reached $155.78 million.
Considering the fact that the conglomerate employs 264 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 88.22%, operating margin of -0.19%, and the pretax margin is -5.24%.
TG Therapeutics Inc (TGTX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward TG Therapeutics Inc stocks. The insider ownership of TG Therapeutics Inc is 9.73%, while institutional ownership is 65.78%. The most recent insider transaction that took place on Jan 03 ’25, was worth 343,443. In this transaction CFO of this company sold 11,337 shares at a rate of $30.29, taking the stock ownership to the 670,632 shares. Before that another transaction happened on Jan 06 ’25, when Company’s CFO sold 10,021 for $28.53, making the entire transaction worth $285,939. This insider now owns 660,611 shares in total.
TG Therapeutics Inc (TGTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.22% per share during the next fiscal year.
TG Therapeutics Inc (NASDAQ: TGTX) Trading Performance Indicators
You can see what TG Therapeutics Inc (TGTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.11, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 1.01 in one year’s time.
Technical Analysis of TG Therapeutics Inc (TGTX)
Compared to the last year’s volume of 2.79 million, its volume of 2.11 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 65.88%. Additionally, its Average True Range was 1.64.
During the past 100 days, TG Therapeutics Inc’s (TGTX) raw stochastic average was set at 64.53%, which indicates a significant decrease from 96.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.43% in the past 14 days, which was lower than the 63.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.59, while its 200-day Moving Average is $22.96. Nevertheless, the first resistance level for the watch stands at $32.21 in the near term. At $33.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $35.04. If the price goes on to break the first support level at $29.38, it is likely to go to the next support level at $27.49. Now, if the price goes above the second support level, the third support stands at $26.55.
TG Therapeutics Inc (NASDAQ: TGTX) Key Stats
There are 155,665K outstanding shares of the company, which has a market capitalization of 4.87 billion. As of now, sales total 233,660 K while income totals 12,670 K. Its latest quarter income was 83,880 K while its last quarter net income were 3,880 K.
